| Record ID | marc_loc_2016/BooksAll.2016.part20.utf8:221442957:1095 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part20.utf8:221442957:1095?format=raw |
LEADER: 01095cam a2200313 a 4500
001 91007026
003 DLC
005 19930812103442.6
008 910305s1991 maua b 001 0 eng c
010 $a 91007026 //r93
020 $a0792312120
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC271.C5$bM644 1991
060 $aW1 CA693 v. 57$aQZ 267 M7184
082 00 $a616.99/4061$220
245 00 $aMolecular and clinical advances in anticancer drug resistance /$cedited by Robert F. Ozols.
260 0 $aBoston :$bKluwer Academic Publishers,$c1991.
300 $axii, 308 p. :$bill. ;$c25 cm.
490 1 $aCancer treatment and research ;$v57
504 $aIncludes bibliographical references and index.
650 0 $aDrug resistance in cancer cells.
650 2 $aAlkylating Agents$xpharmacology.
650 2 $aDoxorubicin$xpharmacology.
650 2 $aDrug Resistance$xgenetics.
650 2 $aMembrane Glycoproteins$xgenetics.
650 2 $aNeoplasms$xdrug therapy.
650 2 $aVinblastine$xpharmacology.
700 10 $aOzols, Robert F.
830 0 $aCancer treatment and research ;$vv. 57.